MODULATION OF OLFML-3 MEDIATED ANGIOGENESIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110287088A1
SERIAL NO

13131491

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to nucleic acids and antibodies against Olfml-3 and Olfml-3 protein function in angiogenesis. Angiogenesis-related conditions, such as cancer or wound healing, can be treated by the composition comprising the Olfml-3 antagonists or agonists, respectively.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RESEARCH DEVELOPMENT FOUNDATION402 NORTH DIVISION STREET CARSON CITY NV 89703

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hammel, Philippe Geneva, CH 9 10
Imhof, Beat A Geneva, CH 14 38
Miljkovic-Licina, Marijana Geneva, CH 9 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation